Understanding Value Stocks
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
The following stocks are considered to be notable value stocks in the healthcare sector:
- Nuwellis (NASDAQ:NUWE) - P/E: 0.02
- Exicure (NASDAQ:XCUR) - P/E: 0.33
- Acorda Therapeutics (NASDAQ:ACOR) - P/E: 3.69
- Prenetics Global (NASDAQ:PRE) - P/E: 0.24
- Ocuphire Pharma (NASDAQ:OCUP) - P/E: 2.03
Most recently, Nuwellis reported earnings per share at $-1.81, whereas in Q2 earnings per share sat at $-3.65. Exicure has reported Q2 earnings per share at $-0.68, which has increased by 2.86% compared to Q1, which was -0.7. Acorda Therapeutics's earnings per share for Q3 sits at $-7.16, whereas in Q2, they were at -7.55. Prenetics Global looks to be undervalued. It possesses an EPS of $-0.05, which has not changed since last quarter (Q2). Most recently, the company reported a dividend yield of 1.99%, which has decreased by 0.02% from last quarter's yield of 2.01%.
Ocuphire Pharma saw an increase in earnings per share from -0.24 in Q2 to $0.25 now.
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.